Orchid Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
959.65
9.2 (0.97%)
BSENSE

Nov 20

BSE+NSE Vol: 70.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
341.27
304.17
368.33
207.27
298.46
263.19
237.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
341.27
304.17
368.33
207.27
298.46
263.19
237.48
Raw Material Cost
245.96
206.42
209.84
118.97
172.05
203.70
136.94
Purchase of Finished goods
1.42
0.61
0.48
0.25
0.17
0.79
1.24
(Increase) / Decrease In Stocks
-38.95
-2.72
35.12
23.93
34.79
-21.09
-0.17
Employee Cost
31.41
28.04
27.62
24.13
31.44
27.70
22.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
77.29
57.83
65.11
38.42
56.93
57.74
49.24
Total Expenditure (Excl Depreciation)
317.13
290.17
338.17
205.70
295.38
268.83
209.50
Operating Profit (PBDIT) excl Other Income
24.14
14.00
30.16
1.57
3.08
-5.64
27.98
Other Income
17.76
1.83
7.77
5.61
11.64
11.57
3.90
Operating Profit (PBDIT)
41.90
15.83
37.93
7.18
14.72
5.93
31.88
Interest
3.64
2.23
1.96
3.18
2.57
2.28
3.92
Exceptional Items
0.00
0.00
-0.22
-7.11
0.00
0.00
0.00
Gross Profit (PBDT)
38.26
13.60
35.75
-3.11
12.15
3.65
27.96
Depreciation
11.41
10.95
10.90
9.03
10.81
10.53
8.87
Profit Before Tax
26.84
2.65
24.85
-12.15
1.34
-6.89
19.09
Tax
-0.04
0.07
0.00
0.00
-0.15
0.00
-0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26.88
2.58
24.84
-12.15
1.49
-6.89
19.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26.88
2.58
24.84
-12.15
1.49
-6.89
19.13
Share in Profit of Associates
1.71
0.65
1.00
-0.47
-2.39
1.20
3.16
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.59
3.22
25.84
-12.61
-0.90
-5.69
22.29
Equity Capital
59.89
59.89
59.89
50.72
50.72
59.89
50.72
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,572.40
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.77
0.54
4.31
-2.49
-0.18
-0.95
4.39
Diluted Earnings per share
4.77
0.54
4.31
-2.49
-0.15
-0.95
4.4
Operating Profit Margin (Excl OI)
7.07%
4.6%
8.19%
0.76%
1.03%
-2.14%
11.78%
Gross Profit Margin
11.21%
4.47%
9.71%
-1.5%
4.07%
1.39%
11.77%
PAT Margin
7.88%
0.85%
6.74%
-5.86%
0.5%
-2.62%
8.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 12.20% vs -17.42% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 787.89% vs -87.54% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 72.43% vs -53.58% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 63.23% vs 13.78% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Orchid Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
341.27
496.30
-155.03
-31.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
341.27
496.30
-155.03
-31.24%
Raw Material Cost
245.96
325.10
-79.14
-24.34%
Purchase of Finished goods
1.42
10.48
-9.06
-86.45%
(Increase) / Decrease In Stocks
-38.95
-3.98
-34.97
-878.64%
Employee Cost
31.41
45.08
-13.67
-30.32%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
77.29
49.66
27.63
55.64%
Total Expenditure (Excl Depreciation)
317.13
426.35
-109.22
-25.62%
Operating Profit (PBDIT) excl Other Income
24.14
69.95
-45.81
-65.49%
Other Income
17.76
2.46
15.30
621.95%
Operating Profit (PBDIT)
41.90
72.41
-30.51
-42.14%
Interest
3.64
4.27
-0.63
-14.75%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
38.26
68.14
-29.88
-43.85%
Depreciation
11.41
11.84
-0.43
-3.63%
Profit Before Tax
26.84
56.30
-29.46
-52.33%
Tax
-0.04
13.88
-13.92
-100.29%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
26.88
42.42
-15.54
-36.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
26.88
42.42
-15.54
-36.63%
Share in Profit of Associates
1.71
0.00
1.71
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.59
42.42
-13.83
-32.60%
Equity Capital
59.89
57.23
2.66
4.65%
Face Value
10.00
10.00
0.00
Reserves
1,572.40
0.00
1,572.40
Earnings per share (EPS)
4.77
7.41
-2.64
-35.63%
Diluted Earnings per share
4.77
7.40
-2.63
-35.54%
Operating Profit Margin (Excl OI)
7.07%
14.09%
0.00
-7.02%
Gross Profit Margin
11.21%
13.73%
0.00
-2.52%
PAT Margin
7.88%
8.55%
0.00
-0.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 341.27 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 12.20% vs -17.42% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 14.34% vs 34.02% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 28.59 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 787.89% vs -87.54% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 3,276.67% vs -103.30% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.14 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 72.43% vs -53.58% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 683.77% vs -89.85% in Sep 2025

Quarterly - Interest
Interest 3.64 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 63.23% vs 13.78% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 41.63% vs -22.82% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.07%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025